Studies in middle-aged adults suggest that daily aspirin can reduce the risk of cancer, but it’s a different story for people aged 70 or older. The ASPREE study found no effect on overall cancer ...

People who regularly take aspirin for a prolonged period of time are six times more likely to develop Crohn's disease. “In a middle-aged to elderly population, aspirin use may be relevant in nearly 1 ...

Once seen as a simple way to protect the heart, daily aspirin is now being reconsidered as experts warn that for healthy ...

Long-term evaluation of the randomized ASPREE trial and an observational follow-up study confirmed prior results that low-dose aspirin did not reduce cancer incidence among older adults and ...

Among the delivery characteristics and neonatal outcomes, the researchers found a slightly lower rate of preterm birth (<37 ...

New recommendations about aspirin, heart health and colon cancer have left many people confused. Here’s what you need to know. By Tara Parker-Pope For years, many doctors have recommended that people ...

Learn how a staple from our medicine cabinet has the potential to support the immune system in combating metastatic cancer. Every day, around 29 million people in the U.S. take a low dose of aspirin ...

ANAHEIM, Calif. -- Some patients may be taking aspirin inappropriately, two single-center retrospective studies found. In the first study, conducted at general medicine units at an academic medical ...

These findings, published in JAMA Oncology, suggest that the protective benefits of aspirin seen in younger populations do not translate to adults older than 70 years.

Universal aspirin dispensation at the first prenatal visit is associated with reduced development of preeclampsia with severe features (SPE).